Iron Triangle Partners LP Repligen Corp Transaction History

Iron Triangle Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $9.42 Million - $15.3 Million	82,537 New	82,537 $14.8 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $12.7 Million - $17.2 Million	78,000 Added 78.0%	178,000 $30.1 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $24.1 Million - $38.4 Million	-150,000 Reduced 60.0%	100,000 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $35.2 Million - $47 Million	250,000 New	250,000 $40.6 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $12.7 Million - $16.4 Million	-150,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $11.1 Million - $14 Million	150,000 New	150,000 $13.9 Million

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

Stay updated on Iron Triangle Partners LP with notifications on news.